LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease
Advanced Science · 2023
DOI: 10.1002/advs.202303711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Longping Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, First Affiliated Hospital of Nanchang University, Nanchang, 330209, P. R. China. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
The gene mutations of LRRK2, which encodes leucine‐rich repeat kinase 2 (LRRK2), are associated with one of the most prevalent monogenic forms of Parkinson's disease (PD). However, the potential effectors of the Gly2019Ser (G2019S) mutation remain unknown. In this study, the authors investigate the effects of LRRK2 G2019S on endoplasmic reticulum (ER) stress in induced pluripotent stem cell (iPSC)‐induced dopamine neurons and explore potential therapeutic targets in mice model. These findings demonstrate that LRRK2 G2019S significantly promotes ER stress in neurons and mice. Interestingly, inhibiting LRRK2 activity can ameliorate ER stress induced by the mutation. Moreover, LRRK2 mutation can induce ER stress by directly interacting with thrombospondin‐1/transforming growth factor beta1 (THBS1/TGF‐β1). Inhibition of LRRK2 kinase activity can effectively suppress ER stress and the expression of THBS1/TGF‐β1. Knocking down THBS1 can rescue ER stress by interacting with TGF‐β1 and behavior burden caused by the LRRK2 mutation, while suppression of TGF‐β1 has a similar effect. Overall, it is demonstrated that the LRRK2 mutation promotes ER stress by directly interacting with THBS1/TGF‐β1, leading to neural death in PD. These findings provide valuable insights into the pathogenesis of PD, highlighting potential diagnostic markers and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, First Affiliated Hospital of Nanchang University, Nanchang, 330209, P. R. China.
- Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, P. R. China.
- Institute for Anatomy and Cell Biology, Medical Faculty, Heidelberg University, 69120, Heidelberg, Germany.
- Department of Neuroscience, Institute of Health Sciences, Ondokuz Mayıs University, Samsun, 55139, Turkey.
ORCID-Profile: Longping Yao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Yao, L., Lu, F., Koc, S., Zheng, Z., Wang, B., Zhang, S., Skutella, T., & Lu, G. (2023). LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease. Advanced Science. https://doi.org/10.1002/advs.202303711
Vancouver
Yao L, Lu F, Koc S, Zheng Z, Wang B, Zhang S, et al. LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease. Advanced Science. 2023. doi:10.1002/advs.202303711
BibTeX
@article{Yao2023,
author = {Yao, Longping and Lu, Fengfei and Koc, Sumeyye and Zheng, Zijian and Wang, Baoyan and Zhang, Shizhong and Skutella, Thomas and Lu, Guohui},
title = {LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202303711}
}
EUVIMED